vimarsana.com
Home
Live Updates
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus : vimarsana.com
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus
/PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our, "us" or the "Company"), a clinical-stage biotechnology company addressing...
Related Keywords
Jeff Ramson ,
Jonathan Kaufman ,
Lipella Pharmaceuticals ,
Scientific Advisory Board In Oral Health ,
Prnewswire Lipella Pharmaceuticals Inc ,
Drug Administration ,
Nasdaq ,
Lipella Pharmaceuticals Inc ,
Investigational New Drug ,
Scientific Advisory Board ,
Oral Health ,
Michael Chancellor ,
Chief Medical Officer ,
Lichen Planus ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Biotechnology ,
Clinical Trials Amp Medical Discoveries ,
vimarsana.com © 2020. All Rights Reserved.